510(k) K874727
K874727 is an FDA 510(k) premarket notification submitted by Austin Biological Laboratories for the device "PRECEPT(TM) CIPROFLOXACIN". The FDA issued a decision of Substantially Equivalent on Feb 18, 1988. The device falls under product code JWY (Manual Antimicrobial Susceptibility Test Systems), a Class II device regulated under 21 CFR 866.1640. Austin Biological Laboratories has 44 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 18, 1988
- Date Received
- Nov 18, 1987
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Manual Antimicrobial Susceptibility Test Systems
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type
- 510(k)